First 100 Days LogoJoin Us for a Webinar – Thursday, March 30, 2017 1:00 – 2:00 p.m. Eastern

Aggressive enforcement, massive recalls and proactive safety agendas left an indelible impression on the product safety world under the Obama administration. Product safety is no longer a bipartisan affair. But what will the Trump administration mean for your regulatory compliance programs? What changes will we see and how will they affect your safety program?

Join us for a roundtable discussion of what the regulated community can expect under the new administration at the Food & Drug Administration, Consumer Product Safety Commission and the National Highway Safety Administration. We’ll help you to forecast where policy shifts on by focusing on topical discussions of emerging products such as autonomous cars, drones, miniaturized cameras and e-cigarettes, and emerging issues including fire and lithium ion batteries, as well as hacking concerns on interconnected products.

Please click here to register for this webinar, or click here to view the event on

Key topics to be discussed:

  • Taking stock: Where are we now? What happens before new officials at the FDA, NHTSA, CPSC and DOJ are nominated and confirmed?
  • Where and how will the Trump administration affect current agency priorities?
  • Can autonomous vehicle technology and interconnected products thrive in the next four years? Any advantages or hurdles?
  • Will we continue to see aggressive enforcement agendas at the agencies and how will the DOJ respond? How litigious will these agencies be in the coming months and years?
  • What is the future of safety policy and rulemaking? Can these agencies met the EO requiring the repeal of two rules for every one promulgated? And what impact will the federal hiring freeze have on safety programs?


Dan Campbell, Partner

Cheri Falvey, Partner

John Fuson, Partner

Scott Winkelman, Partner

Lauren Bell, Counsel

Matthew Cohen, Counsel

Rebecca Chaney, Counsel

Photo of Daniel T. Campbell Daniel T. Campbell

Dan Campbell is a partner in the Product Liability & Torts Group based in Crowell & Moring’s Washington, D.C. office. He is also a member of the Steering Committee for the firm’s Advertising & Product Risk Management (APRM) Group. Dan primarily represents corporations and organizations faced with product liability and related commercial or contractual disputes throughout the United States. In this capacity, Dan serves as national coordinating counsel, strategic counsel, and trial counsel for companies of all sizes on product liability, warranty, and other personal injury and property damage matters. Dan’s tort and product liability clients span the automotive, railroad, and aviation industries, and include consumer product manufacturers and retailers. Dan also handles complex contract, commercial litigation and arbitration matters for product manufacturers, service providers, and government contractor companies.

Photo of Cheryl A. Falvey Cheryl A. Falvey

Cheryl A. Falvey is a partner in Crowell & Moring’s Washington, D.C. office. She provides litigation and counseling services, with a focus on consumer protection matters, including product safety, privacy, sweepstakes, promotions, and advertising. Cheryl concentrates on the defense of consumer class action, toxic tort, mass tort, and other tort claims arising out of consumer, occupational, and environmental exposures, as well as trade secret, intellectual property, and other technology litigation, representing clients in the food and beverage, consumer product, technology, energy and chemical industry sectors. Cheryl helps clients protect their brand and reputation, avoid liability in the marketing of their products, build safety into their products with science-based risk assessment, and successfully navigate product safety challenges with rapid response. Prior to joining Crowell & Moring, Cheryl served as the general counsel of the CPSC.

Photo of John Fuson John Fuson

John Fuson is a partner in the firm’s Health Care, Advertising & Product Risk Management (APRM), and White Collar and Regulatory Enforcement groups, focusing on U.S. Food and Drug Administration (FDA) enforcement and counseling matters. He is also a member of the Steering Committee for the firm’s APRM Group. Before joining Crowell & Moring, John served as associate chief counsel at the FDA, with broad law enforcement responsibilities, from 2007-2012. John has experience handling all types of major enforcement actions brought by the FDA, including seizure actions, injunction actions, actions for civil money penalties, and contempt actions. His cases have involved drugs, devices, food, and veterinary drugs.

Photo of Scott L. Winkelman Scott L. Winkelman

Scott L. Winkelman is a partner in the firm, co-chair of the Environment, Energy and Resources Group, and a member of the firm’s Management Board and Executive Committee. He litigates class actions, multidistrict proceedings, and other complex litigation nationwide in products and commercial matters. Scott also represents clients in proceedings before the National Highway Traffic Safety Administration, the Consumer Product Safety Commission and related regulatory bodies, and counsels clients on liability prevention, records management, and commercial contract and warranty matters.

Photo of Matthew Cohen Matthew Cohen

Matthew Cohen is a counsel in the firm’s Washington, D.C. office, where he practices in the Product Liability & Torts and Advertising & Product Risk Management groups. Matthew’s practice focuses on litigating complex commercial, mass tort, and product-related disputes in both state and federal courts, and advising companies on consumer product compliance and enforcement issues before the U.S. Consumer Product Safety Commission (CPSC), U.S. Congress, the Federal Trade Commission (FTC), individual states, and Health Canada. In 2014, 2015, and 2016, Matthew was selected by his peers as a “Washington, D.C. Super Lawyers Rising Star” for business litigation.

Photo of Rebecca Baden Chaney Rebecca Baden Chaney

Rebecca Baden Chaney is an associate in the firm’s Washington, D.C. office. Her practice includes a wide-range of product liability litigation and product regulatory counseling matters. She has particular experience representing clients facing claims related to the provision of allegedly defective products. In addition, Rebecca advises clients on a full range of product liability and risk management issues from both the pre-launch and post-launch perspectives. Her regulatory counseling practice focuses primarily on consumer products regulated by the CPSC, as well as automotive parts regulated by NHTSA. In addition, her practice includes white collar defense work, focusing on representing clients before the SEC.